Achieve Life Sciences Inc (ACHV)
Healthcare
Biotechnology
6.40 $
+1.9%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Achieve Life Sciences Inc (ACHV)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 85.2% of the shares are freely tradable; institutional investors hold 61.0%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
61.0%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
0.9%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
85.2%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
8.1%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
103Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Franklin Resources Inc | 4.26 | 4,369,193 | +0.0 | 03/31/2026 |
| Propel Bio Management LLC | 3.69 | 3,786,425 | +0.0 | 12/31/2025 |
| Vanguard Group Inc | 2.41 | 2,474,312 | +0.5 | 12/31/2025 |
| Vanguard Capital Management, LLC | 2.15 | 2,204,714 | +0.0 | 03/31/2026 |
| Simplify Asset Management Inc. | 1.15 | 1,184,512 | +0.0 | 03/31/2026 |
| Millennium Management LLC | 1.05 | 1,077,338 | -20.7 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Franklin Biotechnology Discv A(acc)USD | 2.72 | 2,793,340 | +0.0 | 04/30/2026 |
| Franklin Biotechnology Discovery A | 1.53 | 1,575,682 | +0.0 | 04/30/2026 |
| Vanguard Total Stock Mkt Idx Inv | 1.53 | 1,565,669 | +0.0 | 04/30/2026 |
| Simplify Propel Opportunities ETF | 1.40 | 1,432,105 | +0.0 | 05/29/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.